AVNT three-lens brief
Evidence-based stock research on AVNT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Outperforming SPY by 12.3pp over 30 days.
- Analyst mean target $50.86 — 22% above current (7 analysts).
- Ex-dividend date 2026-09-11.
AVNT closed at $41.72 (-0.43%) as of 2026-09-11. Market cap: $3.83B. P/E (trailing) 22.7. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 12.3pp over 30 days.. Last quarter: Revenue $917.00M, net income $64.80M, free cash flow $263.79M.
Why three lenses on AVNT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AVNTacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AVNT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AVNT brief"></iframe>